Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
Inventory
Samsung Biologics Co Ltd
Inventory Peer Comparison
Competitive Inventory Analysis
Latest Figures & CAGR of Competitors
Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Samsung Biologics Co Ltd
KRX:207940
|
Inventory
₩2.7T
|
CAGR 3-Years
50%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Inventory
₩337.3m
|
CAGR 3-Years
8%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Inventory
₩120.7B
|
CAGR 3-Years
29%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Inventory
₩1.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Inventory
₩196.8m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
C
|
Cellivery Therapeutics Inc
KOSDAQ:268600
|
Inventory
₩6.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
112%
|
CAGR 10-Years
N/A
|
See Also
What is Samsung Biologics Co Ltd's Inventory?
Inventory
2.7T
KRW
Based on the financial report for Mar 31, 2024, Samsung Biologics Co Ltd's Inventory amounts to 2.7T KRW.
What is Samsung Biologics Co Ltd's Inventory growth rate?
Inventory CAGR 5Y
53%
Over the last year, the Inventory growth was 9%. The average annual Inventory growth rates for Samsung Biologics Co Ltd have been 50% over the past three years , 53% over the past five years .